Allergen Challenge
Showing 1 - 25 of 4,117
Allergic Rhinitis Due to Pollen Trial in Stockholm (ITULAZAX 12 SQ-Bet, Placebo tablet, Nacl)
Recruiting
- Allergic Rhinitis Due to Pollen
- ITULAZAX 12 SQ-Bet
- +2 more
-
Stockholm, SwedenKarolinska University Hospital
Oct 19, 2023
Allergic Rhinitis Trial (Nasal allergen challenge)
Recruiting
- Allergic Rhinitis
- Nasal allergen challenge
-
London, United KingdomRoyal Brompton Hospital
Oct 31, 2022
Seasonal Allergic Rhinitis Trial in London (IRL201104, Placebo)
Active, not recruiting
- Seasonal Allergic Rhinitis
- IRL201104
- Placebo
-
London, United Kingdom
- +1 more
Jan 27, 2023
Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)
Recruiting
- Allergic Conjunctivitis
- TL-925
- Placebo
-
Andover, MassachusettsAndover Eye Associates
Nov 29, 2023
Allergic Rhinitis Trial in London (Aquagen, Grazax)
Completed
- Allergic Rhinitis
- Aquagen
- Grazax
-
London, United KingdomRoyal Brompton Hospital
Aug 25, 2021
Asthma Trial in Boston (Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage)
Recruiting
- Asthma
- Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage
-
Boston, MassachusettsMassachusetts General Hospital
Apr 4, 2022
Allergic Rhinitis, Seasonal Allergic Rhinitis, Ragweed Allergy Trial in Hanover (Ragweed pollen, birch pollen, clean air ())
Recruiting
- Allergic Rhinitis
- +3 more
- Ragweed pollen, birch pollen, clean air (placebo)
-
Hanover, Lower Saxony, GermanyFraunhofer Institute for Toxicology and Experimental Medicine
Jul 27, 2022
Asthma, Allergic Asthma, Non-allergic Asthma Trial in Cleveland (Nutritional approach for asthma, Low Caloric Shake, whole lung
Enrolling by invitation
- Asthma
- +2 more
- Nutritional approach for asthma
- +2 more
-
Cleveland, OhioCleveland Clinic
Jul 19, 2022
Asthma, COPD Trial in London, Manchester (SelK2 (Part 1), Placebo (Part 1), SelK2 (Part 2))
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- SelK2 (Part 1)
- +3 more
-
London, United Kingdom
- +1 more
Feb 1, 2022
Allergic Rhinitis Trial in Hannover (Sodium chloride particles, Lactose particles, Clean air)
Completed
- Allergic Rhinitis
- Sodium chloride particles
- +4 more
-
Hannover, Lower Saxony, GermanyFraunhofer Institute for Toxicology and Experimental Medicine
Jul 27, 2022
Allergic Asthma, Allergy to Cats, Allergy to Dust Mites Trial in Iowa City, Boston (Segmental allergen challenge)
Recruiting
- Allergic Asthma
- +4 more
- Segmental allergen challenge
-
Iowa City, Iowa
- +1 more
May 26, 2022
Cat Allergy, Mild Asthma Trial in Strasbourg (REGN1908-1909, Placebo)
Completed
- Cat Allergy
- Mild Asthma
- REGN1908-1909
- Placebo
-
Strasbourg, FranceRegeneron Research Site
Jun 10, 2021
Allergic Conjunctivitis Trial in Andover (VSJ-110, Placebo)
Completed
- Allergic Conjunctivitis
- VSJ-110
- Placebo
-
Andover, MassachusettsVanda Investigational Site
Apr 26, 2022
Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)
Completed
- Allergic Conjunctivitis
- PRT-2761 0.5%
- +4 more
-
Andover, MassachusettsAndover Eye Associates
Oct 13, 2022
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Allergic Conjunctivitis Trial in United States (Bilastine Ophthalmic Solution 0.6%, Ketotifen Ophthalmic Solution 0.025%
Completed
- Allergic Conjunctivitis
- Bilastine Ophthalmic Solution 0.6%
- +2 more
-
Phoenix, Arizona
- +5 more
Nov 16, 2021
Asthma Trial (biological, other, drug)
Withdrawn
- Asthma
- Anakinra
- +2 more
- (no location specified)
May 12, 2021
Asthma Trial (biological, other, drug)
Withdrawn
- Asthma
- Anakinra
- +2 more
- (no location specified)
May 5, 2021
Tobacco Smoking, Healthy Participants, E-cigarette Smokers Trial in Chapel Hill (Felis Domesticus)
Withdrawn
- Tobacco Smoking
- +2 more
- Felis Domesticus
-
Chapel Hill, North CarolinaUNC Center for Environmental Medicine, Asthma and Lung Biology
May 5, 2021
Anaphylaxis Trial in Jerusalem (Epinephrine Nasal Product, 1.6 mg, Epinephrine nasal product, 1.6 mg + allergen, Epinephrine
Completed
- Anaphylaxis
- Epinephrine Nasal Product, 1.6 mg
- +4 more
-
Jerusalem, IsraelHadassah Medical Center, Ein Kerem
Oct 12, 2021